Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 1
2007 4
2008 2
2009 3
2010 5
2011 10
2012 1
2013 3
2014 3
2015 5
2016 5
2017 2
2018 4
2019 6
2020 11
2021 5
2022 11
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous Involvement in Waldenström's Macroglobulinaemia.
Stien S, Durot E, Durlach A, Beylot-Barry M, Adamski H, Beltraminelli H, Bohelay G, Carlotti A, Carpentier O, Cornillet P, Dubois R, Franck N, Husson B, Laroche L, Maubec E, le Clech C, Machet L, Ortonne N, Ram-Wolff C, Vergier B, Grange F. Stien S, et al. Among authors: maubec e. Acta Derm Venereol. 2020 Aug 17;100(15):adv00225. doi: 10.2340/00015555-3535. Acta Derm Venereol. 2020. PMID: 32488284 Free PMC article.
Vaccination-induced cutaneous pseudolymphoma.
Maubec E, Pinquier L, Viguier M, Caux F, Amsler E, Aractingi S, Chafi H, Janin A, Cayuela JM, Dubertret L, Authier FJ, Bachelez H. Maubec E, et al. J Am Acad Dermatol. 2005 Apr;52(4):623-9. doi: 10.1016/j.jaad.2004.12.021. J Am Acad Dermatol. 2005. PMID: 15793512
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial.
Véron M, Chevret S, Grob JJ, Beylot-Barry M, Saiag P, Fléchon A, You B, Maubec E, Jouary T, Toulemonde E, Jamme P, Gambotti L, Lamrani-Ghaouti A, Dupuy A, Lebbe C, Seguin NB, Houede N, Leccia MT, Le Du F, de Pontville M, Gaudy-Marquestre C, Guillot B, Simon C, Marabelle A, Mortier L. Véron M, et al. Among authors: maubec e. Eur J Cancer. 2022 Dec;177:103-111. doi: 10.1016/j.ejca.2022.09.013. Epub 2022 Oct 11. Eur J Cancer. 2022. PMID: 36335780 Clinical Trial.
Sézary syndrome without erythroderma.
Henn A, Michel L, Fite C, Deschamps L, Ortonne N, Ingen-Housz-Oro S, Marinho E, Beylot-Barry M, Bagot M, Laroche L, Crickx B, Maubec E. Henn A, et al. Among authors: maubec e. J Am Acad Dermatol. 2015 Jun;72(6):1003-9.e1. doi: 10.1016/j.jaad.2014.11.015. J Am Acad Dermatol. 2015. PMID: 25981000
Therapy of advanced squamous cell carcinoma of the skin.
Bejar C, Maubec E. Bejar C, et al. Among authors: maubec e. Curr Treat Options Oncol. 2014 Jun;15(2):302-20. doi: 10.1007/s11864-014-0280-x. Curr Treat Options Oncol. 2014. PMID: 24643778 Review.
Recent Advanced in the Treatment of Advanced SCC Tumors.
Basset-Seguin N, Maubec E. Basset-Seguin N, et al. Among authors: maubec e. Cancers (Basel). 2022 Jan 22;14(3):550. doi: 10.3390/cancers14030550. Cancers (Basel). 2022. PMID: 35158818 Free PMC article.
79 results